VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 159 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $37,725 | +109.2% | 6,677 | +52.2% | 0.00% | – |
Q1 2024 | $18,031 | -77.5% | 4,387 | -76.9% | 0.00% | -100.0% |
Q4 2023 | $80,083 | +189.2% | 18,977 | +196.1% | 0.00% | 0.0% |
Q3 2023 | $27,687 | -24.1% | 6,409 | +15.7% | 0.00% | 0.0% |
Q2 2023 | $36,495 | +182375.0% | 5,538 | +91.4% | 0.00% | 0.0% |
Q1 2023 | $20 | +400.0% | 2,894 | +433.0% | 0.00% | – |
Q4 2022 | $4 | -100.0% | 543 | -96.8% | 0.00% | -100.0% |
Q3 2022 | $170,000 | -32.5% | 17,185 | -25.7% | 0.00% | -50.0% |
Q2 2022 | $252,000 | +186.4% | 23,124 | +197.7% | 0.01% | +500.0% |
Q1 2022 | $88,000 | -2.2% | 7,768 | +35.3% | 0.00% | -50.0% |
Q4 2021 | $90,000 | -2.2% | 5,741 | +7.1% | 0.00% | 0.0% |
Q3 2021 | $92,000 | +35.3% | 5,362 | +68.9% | 0.00% | 0.0% |
Q2 2021 | $68,000 | -54.7% | 3,174 | -68.3% | 0.00% | -33.3% |
Q1 2021 | $150,000 | +1775.0% | 9,999 | +1497.3% | 0.00% | – |
Q4 2020 | $8,000 | -72.4% | 626 | -79.3% | 0.00% | – |
Q3 2020 | $29,000 | -85.4% | 3,031 | -82.6% | 0.00% | -100.0% |
Q2 2020 | $199,000 | +1709.1% | 17,444 | +2392.0% | 0.01% | +700.0% |
Q4 2019 | $11,000 | -45.0% | 700 | -51.9% | 0.00% | 0.0% |
Q2 2019 | $20,000 | +900.0% | 1,454 | +1590.7% | 0.00% | – |
Q3 2018 | $2,000 | -75.0% | 86 | -79.3% | 0.00% | – |
Q2 2018 | $8,000 | -78.9% | 416 | -81.4% | 0.00% | -100.0% |
Q1 2018 | $38,000 | +22.6% | 2,232 | +11.0% | 0.00% | -25.0% |
Q4 2017 | $31,000 | +287.5% | 2,011 | +333.4% | 0.00% | +300.0% |
Q3 2017 | $8,000 | -50.0% | 464 | -50.9% | 0.00% | -50.0% |
Q4 2016 | $16,000 | +1500.0% | 945 | +1475.0% | 0.00% | – |
Q3 2016 | $1,000 | -50.0% | 60 | -65.1% | 0.00% | – |
Q2 2016 | $2,000 | – | 172 | +5633.3% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 3 | -99.9% | 0.00% | -100.0% |
Q3 2015 | $52,000 | +4.0% | 4,648 | +19.6% | 0.01% | +25.0% |
Q2 2015 | $50,000 | -24.2% | 3,886 | -44.7% | 0.00% | -50.0% |
Q1 2015 | $66,000 | +65.0% | 7,030 | +154.0% | 0.01% | +100.0% |
Q4 2014 | $40,000 | +1900.0% | 2,768 | +1230.8% | 0.00% | – |
Q3 2014 | $2,000 | -86.7% | 208 | -77.5% | 0.00% | -100.0% |
Q2 2014 | $15,000 | -80.8% | 926 | -86.9% | 0.00% | -75.0% |
Q3 2013 | $78,000 | – | 7,044 | +25057.1% | 0.01% | – |
Q2 2013 | $0 | – | 28 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |